Malignant Tumor Clinical Trials in Shenyang, Liaoning
4 recruitingShenyang, Liaoning, China
Showing 1–4 of 4 trials
Recruiting
First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
Malignant Tumor
First Hospital of China Medical University30 enrolled1 locationNCT07593209
Recruiting
Phase 1
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163
Recruiting
Phase 2
A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy
MSI-H Solid Malignant Tumor
Shanghai Henlius Biotech108 enrolled33 locationsNCT03941574